eScholarshipmetadata only
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer
32 biomedical and clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), 3204 immunology (for-2020), rare diseases (rcdc), sexually transmitted infections (rcdc), immunization (rcdc), clinical research (rcdc), vaccine related (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 784311
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.